SAGE Therapeutics (SAGE) Commences $500M Offering of Common Stock
February 25, 2019 4:02 PM
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
